Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
DFTX
Stock Latest News
The Fly
Definium Therapeutics initiated with an Overweight at Piper Sandler
2d ago
DFTX
Premium
The Fly
Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial
10d ago
ATAI
CMND
Premium
The Fly
Definium Therapeutics announces publication of study on general anxiety disorder
12d ago
DFTX
Premium
Company Announcements
Mind Medicine Readies for Data-Rich 2026 Pivot
1M ago
DFTX
Premium
The Fly
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results
1M ago
PBM
ATAI
Premium
The Fly
Definium Therapeutics price target raised to $40 from $18 at Maxim
1M ago
DFTX
Premium
Ratings
Definium Therapeutics: Late-Stage Pipeline Progress and Upcoming Phase 3 Readouts Support Buy Rating and Favorable Risk-Reward
1M ago
DFTX
Premium
Company Announcements
Definium Therapeutics Issues Inducement Stock Options to New Hires
1M ago
DFTX
Premium
Company Announcements
Definium Therapeutics Sets Webcast to Unveil 2025 Results and Business Update
1M ago
DFTX
Premium
Company Announcements
Definium Therapeutics to Highlight Pipeline at Series of March Investor Conferences
1M ago
DFTX
Premium
The Fly
Definium Therapeutics reports FY25 EPS ($2.06), consensus ($2.00)
1M ago
DFTX
Premium
The Fly
Psychedelic: AtaiBeckley reports EMP-01 met primary objective in Phase 2a trial
1M ago
PFE
ABBV
Premium
Pre-Earnings
Is MNMD a Buy, Before Earnings?
2M ago
DFTX
Premium
The Fly
Definium Therapeutics initiated with an Outperform at Wolfe Research
2M ago
DFTX
Premium
The Fly
Psychedelic: Exclusive talk with nonprofit organization MAPS
2M ago
ATAI
CMND
Premium
The Fly
Psychedelic: Analyst initiates Definium, Helus with Buy ratings
2M ago
CMND
DFTX
Premium
The Fly
Spotify upgraded, Pinterest downgraded: Wall Street’s top analyst calls
2M ago
ALC
DGX
Premium
The Fly
Definium Therapeutics initiated with a Buy at Jefferies
2M ago
DFTX
Premium
The Fly
Psychedelic: Analyst raises Compass, Definium, GH Research price targets
2M ago
PBM
CMPS
Premium
The Fly
Definium Therapeutics appoints Roger Adsett to board of directors
2M ago
DFTX
INSM
Premium
Company Announcements
Definium Therapeutics Expands Board, Appoints New Director
2M ago
8K
DFTX
Premium
The Fly
Definium Therapeutics price target raised to $37 from $16 at Baird
2M ago
DFTX
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
